Mengyi Lao
-
- Pancreatic and Hepatic Oncology Research 11
- Cancer Immunotherapy and Biomarkers 5
-
- Immune cells in cancer 4
-
- Gallbladder and Bile Duct Disorders 3
- Ferroptosis and cancer prognosis 2
-
- Pancreatitis Pathology and Treatment 3
-
- Neuroendocrine Tumor Research Advances 2
- Autophagy in Disease and Therapy 2
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Mengyi Lao
20 papers receiving 350 citations
Peers
Comparison fields: 5 of 49
- Oncology 215
- Immunology 105
- Cancer Research 42
- Pulmonary and Respiratory Medicine 86
- Molecular Biology 133
Countries citing papers authored by Mengyi Lao
This map shows the geographic impact of Mengyi Lao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengyi Lao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengyi Lao more than expected).
Fields of papers citing papers by Mengyi Lao
This network shows the impact of papers produced by Mengyi Lao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengyi Lao. The network helps show where Mengyi Lao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengyi Lao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 39 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 46 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 44 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 83 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 34 | |
| 16 | 2019 | 28 | |
| 17 | 2019 | 12 | |
| 18 | 2019 | 6 | |
| 19 | 2018 | 3 | |
| 20 | 2018 | 7 |
About Mengyi Lao
Mengyi Lao is a scholar working on Oncology, Immunology and Hepatology, having authored 21 papers that have together received 351 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (4 papers), Pancreatitis Pathology and Treatment (3 papers), Gallbladder and Bile Duct Disorders (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Ferroptosis and cancer prognosis (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Oncology (215 citations), Immunology (105 citations) and Cancer Research (42 citations). Mengyi Lao has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Tingbo Liang, Xiaozhen Zhang, Jian Xu, Xueli Bai, Hanshen Yang, Chengxiang Guo, Honggang Ying, Yi Duan, Xueli Bai and Lihong He. Their work appears in journals such as Nature Communications, Oncogene and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.